Massive intracerebral aspergillosis responding to combination high dose liposomal amphotericin B and cytokine therapy without surgery

Journal of Medical Microbiology

Volumn 51, Issue 1, 2002, Pages 70-75

  Ellis, Michael ^a   Watson, R ^a   McNabb, A ^a   Lukic, M L ^a   Nork, M ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CYTOKINE; DEXAMETHASONE; FLUCYTOSINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOMODULATING AGENT; ITRACONAZOLE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RIFAMPICIN;

ADULT; ARTICLE; ASPERGILLOSIS; BRAIN INFECTION; CASE REPORT; CELL INFILTRATION; COMBINATION CHEMOTHERAPY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; LIVER TOXICITY; OPTIC NERVE; PRIORITY JOURNAL; SURGICAL RISK; TREATMENT OUTCOME;

EID: 0036142625     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-51-1-70     Document Type: Article

References (8)

1. A new classification and diagnostic criteria for invasive fungal sinusitis
2. Skull base osteitis following fungal sinusitis
3. Aspergillus fumigatus and aspergillosis
4. Invasive intracranial aspergillosis secondary to intranasal corticosteroids
5. Antifungal and surgical treatment of invasive aspergillosis: Review of 2,121 published cases
6. Invasive central nervous system aspergillosis: Cure with liposomal amphotericin B, itraconaxole, and radical surgery - A case report and review of the literature
7. Combination immunotherapy and antifungal chemotherapy
8. Macrophage inflammatory protein-lα is a critical mediator of host defences against invasive pulmonary aspergillosis in neutropenic hosts